Azedine Barik, PhD
Mr. Barik has a combined Biology/Chemistry B.Sc. from Surrey University (U.K.) and a PhD in Immunology from London University (U.K.). He worked for over 10 years in an American biopharmaceutical company; Therapeutic Antibodies, Inc, where he managed the preclinical, clinical and pharmaceutical development (CMC) of a number of drug candidates. After arriving in Japan in 1994, Dr. Barik worked as a biomedical writing consultant for a number of Japanese pharmaceutical companies before founding PMP Consulting Co., Ltd in 1995. As CEO of PMP Consulting, Dr. Barik has over the past 20 years helped a number of clients develop effective preclinical / clinical research, CMC strategies and manufacturing / quality control operations. He is currently involved in a number of strategic projects and provides various seminars on technical and regulatory issues related to pharmaceutical development (CMC), excipients GMP, and drug packaging qualification and quality control. Dr. Barik is regularly invited to oversee on-the-job training at a number of pharma companies and coordinate internal / supplier audits.

Toru Hibi
Mr. Hibi graduated from Kyoto University School of Pharmacy (Japan) with a Master Degree (M.SC.) in Natural Organic Chemistry and joined a large chemical company where he conducted research on the development of pesticides. Mr. Hibi was then offered a position at a Swiss-based multinational pharmaceutical company where he engaged in the pharmaceutical development of a number of drug candidates. He was then transferred to the company’s affiliate in the U.S. and spent one year under the guidance of Prof. Takeru Higuchi at the University Kansas/School of Pharmacy and another taking a specialized training. After returning to Japan, Mr. Hibi joined a pharmaceutical company specializing in transdermal patches and was appointed Head of R&D. In 2004, Mr. Hibi returned to the U.S where he worked for another 7 years as Head of R&D at Teikoku Pharma USA (TPU). Currently Mr. Hibi is based in Japan and works as pharma consultant for Pharma Seeds Create LLC and PMP Consulting Co., Ltd. He also acts as Asia agent for the French pharma company Pierre Fabre CDMO/CMO Injections and as R&D advisor to Daido Chemical Co., Ltd.

Shigeru Enomoto
Mr. Enomoto has a Bachelor Degree (B.Sc.) in Pharmaceutical Sciences from the University of Kyoto (Japan) and an MBA from Stanford Graduate School of Business (USA). He worked for a number of years at Takeda Pharmaceuticals in Germany and served as a Board Member at Maruishi Pharma (Japan). Mr. Enomoto also worked in a number of other pharmaceutical companies as Head of Business Strategy, Head of R&D, and Head of Production and Marketing. Having broad knowledge of pharmaceuticals, Mr. Enomoto is able to engage in a number of alliances and currently serves as CEO of Valneva Toyama Japan, a subsidiary of a French biotechnology company, and as President at JPC Holdings. Mr. Enomoto also serves as Director of Pharma Delegates and Chairman of Kansai Pharma Licensing Association.

Koji Noguchi
Mr. Noguchi graduated from Kobe University (Japan) with a Bachelor Degree (B.Sc.) in Agricultural Chemistry and spent the next 37 working in a multinational pharma company both in Japan and abroad. He was first engaged in the development of solid/sustained release dosage forms and then in the establishment of a global IT application system for R&D as IT Project Manager/Quality Manager. Mr. Noguchi next responsibility was Head of Operations of the Drug Development division where he oversaw Sourcing, Vendor Management, Risk Management (BRM), Business Continuity Management (BCP), Information Security and Compliance training. Through such broad experience, Mr. Noguchi became an expert in IT strategy, Project Management, Computer System Validation (CSV), Quality/Records Management and Information Security. He is result-driven, quality focused, and had strong commitment.